Flanking sequences modulate diepoxide and mustard cross-linking efficiencies at the 5′-GNC site

Chemical Research in Toxicology

Volumn 17, Issue 8, 2004, Pages 1057-1063

  Sawyer, Gregory A ^a   Frederick, Elizabeth D ^a   Millard, Julie T ^a  

^a Health Services and Department of Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTADIENE DIEPOXIDE; CHLORMETHINE; CYTOTOXIC AGENT; DEOXYGUANOSINE; DIEPOXYOCTANE; DOUBLE STRANDED DNA; EPOXIDE; MUSTARD GAS DERIVATIVE; OLIGOMER; PIPERIDINE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BASE PAIRING; CROSS LINKING; DNA FLANKING REGION; POLYACRYLAMIDE GEL ELECTROPHORESIS;

BASE SEQUENCE; CROSS-LINKING REAGENTS; DEOXYGUANOSINE; DNA; ELECTROPHORESIS; EPOXY COMPOUNDS; MECHLORETHAMINE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; TIME FACTORS;

SYNTHETIC CONSTRUCT;

EID: 4344708115     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0499057     Document Type: Article

References (48)

1. Krumbhaar, E. B., and Krumbhaar, H. D. (1919) The blood and bone marrow in yellow cross gas (mustard gas) poisoning. J. Med. Res. 40, 497-509.
2. Lawley, P. D. (1995) DNA alkylation and its aftermath. BioEssays 17, 561-568.
3. Hartley, J. A., O'Hare, C. C., and Baumgart, J. (1999) DNA alkylation and interstrand cross-linking by treosulfan. Br. J. Cancer 79, 264-266.
4. McCammon, C. J., Kotin, P., and Falk, H. L. (1957) The cancerogenic potency of certain diepoxides. Proc. Am. Assoc. Cancer Res. 2, 229-230.
5. International Agency for Research on Cancer (IARC) (1976) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man; Cadmium, Nickel, and Some Epoxides, Miscellaneous Industrial Chemicals and General Considerations on Volatile Anaesthetics, Vol. 11, pp 115-123, IARC, Lyon, France.
6. International Agency for Research on Cancer (IARC) (1999) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man; Reevaluation of some Organic Chemicals, Hydrazine, and Hydrogen Peroxide, Vol. 71, pp 109-225, IARC, Lyon, France.
7. Divine, B. J. (1990) An update on mortality among workers at a 1,3-butadiene facility. Environ. Health Perspect. 86, 119-128.
8. Mehlman, M. A., and Legator, M. S. (1991) Dangerous and cancer-causing properties of products and chemicals in the oil refining and petrochemical industry- Part II: carcinogenicity, mutagenicity, and developmental toxicity of 1,3-butadiene. Toxicol. Ind. Health 7, 207-220.
9. Divine, B. J., Wendt, J. K., and Hartman, C. M. (1993) Cancer mortality among workers at a butadiene production facility. In Butadiene and Styrène: Assessment of Health Hazards (Sorsa, M., Peltonen, K., Vainio, H., and Hemminki, K., Eds.) pp 345-362, IARC Scientific Publications No. 127, IARC, Lyon, France.
10. Macaluso, M., Larson, R., Delzell, E., Sathiakumar, N., Hovinga, M., Julian, J., Muir, D., and Cole, P. (1996) Leukemia and cumulative exposure to butadiene, styrene, and benzene among workers in the synthetic rubber industry. Toxicology 113, 190-202.
11. Albertini, R., Clewell, H., Himmelstein, M. W., Morinello, E., Olin, S., Preston, J., Scarano, L., Smith, M. T., Swenberg, J., Tice, R., and Travis, C. (2003) The use of nontumor data in cancer risk assessment: reflections on butadiene, vinylchloride, and benzene. Regal. Toxicol. Pharmacol. 37, 105-132.
12. Mullins, J. A. (1990) Industrial emissions of 1,3-butadiene. Environ. Health Perspect. 86, 9-10.
13. Rustemeier, K., Stabbert, R., Haussmann, H.-J., Roemer, E., and Carmines, E. L. (2002) Evaluation of the potential effects of ingredients added to cigarettes. Part 2: Chemical composition of mainstream smoke. Food Chem. Toxicol. 40, 93-104.
14. Jacobson-Kram, D., and Rosenthal, S. L. (1995) Molecular and genetic toxicology of 1,3-butadiene. Mutat. Res. 339, 121-130.
15. Malvoisin, E., and Roberfroid, M. (1982) Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica 12, 137-144.
16. Henderson, R. F., Bechtold, W. E., Sabourin, P. J., Maples, K. R., and Dahl, A. R. (1993) Species differences in the metabolism of 1,3-butadiene in vivo. In Butadiene and Styrene: Assessment of Health Hazards (Sorsa, M., Peltonen, K., Vainio, H., and Hemminki, K., Eds.) pp 57-64, IARC Scientific Publications No. 127, IARC, Lyon, France.
17. Cochrane, J. E., and Skopek, T. R. (1994) Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis 15, 713-717.
18. Brooks, P., and Lawley, P. D. (1961) The reaction of mono- and di-functional alkylating agents with nucleic acids. Biochem. J. 80, 496-503.
19. Ojwang, J. O., Grueneberg, D. A., and Loechler, E. L. (1989) Synthesis of a duplex oligonucleotide containing a nitrogen mustard interstrand DNA-DNA cross-link. Cancer Res. 49, 6529-6537.
20. Millard, J. T., Raucher, S., and Hopkins, P. B. (1990) Mechlorethamine cross-links deoxyguanosine residues at 5′-GNC sequences in duplex DNA fragments. J. Am. Chem. Soc. 112, 2459-2460.
21. Rink, S. M., Solomon, M. S., Taylor, M. J., Rajur, S. B., McLaughlin, L. W., and Hopkins, P. B. (1995) Covalent structure of a nitrogen mustard-induced DNA interstrand cross-link: an N7-to-N7 linkage of deoxyguanosine residues at the duplex sequence 5-d(GNC). J. Am. Chem. Soc. 115, 2551-2557.
22. Millard, J. T., and White, M. M. (1993) Diepoxybutane cross-links DNA at 5′-GNC sequences. Biochemistry 32, 2120-2124.
23. Yunes, M. J., Charnecki, S. E., Marden, J. J., and Millard, J. T. (1996) 1,2,5,6-Diepoxyhexane and 1,2,7,8-diepoxyoctane cross-link duplex DNA at 5′-GNC sequences. Chem. Res. Toxicol. 9, 994-1000.
24. Millard, J. T., Luedtke, N. W., and Spencer, R. J. (1996) The 5′-GNC preference for mustard cross-linking is preserved in a restriction fragment. Anti-Cancer Drug Des. 11, 485-492.
25. Millard, J. T., and Wilkes, E. E. (2001) Diepoxybutane and diepoxyoctane interstrand cross-linking of the 5S DNA nucleosomal core particle. Biochemistry 40, 10677-10685.
26. Hopkins, P. B., Millard, J. T., Woo, J., Weidner, M. F., Kirchner, J. J., Sigurdsson, S. T., and Raucher, S. (1991) Sequence preferences of DNA interstrand cross-linking agents: importance of minimal DNA structural reorganization in the cross-linking reactions of mechlorethamine, cisplatin, and mitomycin C. Tetrahedron 47, 2475-2489.
27. Chawla, A. K., Lipman, R., and Tomasz, M. (1987) Covalent cross-links and monofunctional adducts of mitomycin C in the minor groove of DNA: Effects on DNA conformation and dynamics. In Structure and Expression, Volume 2: DNA and Its Drug Complexes (Sarma, and Sarma, Eds.) pp 305-316, Adenine Press, Guilderland, NY.
28. Teng, S. P., Woodson, S. A., and Crothers, D. M. (1989) DNA sequence specificity of mitomycin cross-linking. Biochemistry 28, 3901-3907.
29. Weidner, M. F., Millard, J. T., and Hopkins, P. B. (1989) Determination at single-nucleotide resolution of the sequence specificity of DNA interstrand cross-linking agents in DNA fragments. J. Am. Chem. Soc. 111, 9270-9272.
30. Borowy-Borowski, H., Lipman, R., and Tomasz, M. (1990) Recognition between mitomycin C and specific DNA sequences for cross-link formation. Biochemistry 29, 2999-3006.
31. Millard, J. T., Weidner, M. F., Raucher, S., and Hopkins, P. B. (1990) Determination of the DNA cross-linking sequence specificity of reductively activated mitomycin C at single-nucleotide resolution: deoxyguanosine residues at CpG are cross-linked preferentially. J. Am. Chem. Soc. 112, 3637-3641.
32. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
33. Maxam, A. M., and Gilbert, W. (1980) Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65, 499-560.
34. Bauer, G. B., and Povirk, L. F. (1997) Specificity and kinetics of interstrand and intrastrand bifunctional alkylation by nitrogen mustards at a G-G-C sequence. Nucleic Acids Res. 25, 1211-1218.
35. Kaldor, J. M., Day, N. E., Clarke, E. A., Van Leeuwen, F. E., Henry-Amar, M., Florentine, M. V., Bell, J., Pedersen, D., Band, P., Assouline, D., Koch, M., Choi, W., Prior, P., Blair, V., Langmark, F., Kirn, V. P., Neal, F., Peters, D., Pfeiffer, R., Karjalainen, S., Cuzick, J., Sutcliffe, S. B., Somers, R., Pellae-Cosset, B., Pappagallo, G. L., Fraser, P., Storm, H., and Stovall, M. (1990) Leukemia risk following Hodgkin's disease. N. Engl. J. Med. 322, 7-13.
36. van Leeuwen, F. E., Chorus, A. M., van den Belt-Dusebout, A. W., Hagenbeek, A., Noyon, R., van Kerkhoff, E. H., Pinedo, H. M., and Somers, R. (1994) Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J. Clin. Oncol. 12, 1063-1073.
37. Doerr, J. K., Hollis, E. Á., and Sipes, I. G. (1996) Species differences in the ovarian toxicity of 1,3-butadiene epoxides in B6C3Fi mice and Sprague-Dawley rats. Toxicology 113, 128-136.
38. Grunber, S. M., and Haseltine, W. A. (1980) Use of an indicator sequence of human DNA to study DNA damage by methylbis(2-chloroethyl)amine. Proc. Natl. Acad. Sci. U.S.A. 77, 6546-6550.
39. Mattes, W. B., Hartley, J. A., and Kohn, K. W. (1986) DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards. Nucleic Acids Res. 14, 2971-2987.
40. Hartley, J. A., Gibson, N. W., Kohn, K. W., and Mattes, W. B. (1986) DNA sequence selectivity of guanine-N7 alkylation by three antitumor chloroethylating agents. Cancer Res. 46, 1943-1947.
41. Kohn, K. W., Hartley, J. W., and Mattes, W. B. (1987) Mechanisms of DNA sequence selective alkylation of guanine-N7 positions by nitrogen mustards. Nucleic Acids Res. 15, 10531-10549.
42. Hausheer, F. H., Singh, U. C., Saxe, J. D., and Colvin, O. M. (1989) Identification of local determinants of DNA interstrand cross-link formation by cyclophosphamide metabolites. Anti-Cancer Drug Des. 4, 281-294.
43. Rink, S. M., and Hopkins, P. B. (1995) A mechlorethamine-induced DNA interstrand cross-link bends duplex DNA. Biochemistry 34, 1439-1445.
44. Van Duuren, B. L. (1969) Carcinogenic epoxides, lactones, and halo-ethers and their mode of action. Ann. N. Y. Acad. Sci. 163, 633-651.
45. Goodsell, D. S., Kopka, M. L., Cascio, D., and Dickerson, R. E. (1993) Crystal structure of CATGGCCATG and its implications for A-tract bending models. Proc. Natl. Acad. Sci. U.S.A. 90, 2930-2934.
46. Pullman, A., and Pullman, B. (1981) Molecular electrostatic potential of the nucleic acids. Q. Rev. Biophys. 14, 289-380.
47. Dornberger, U., Leijon, M., and Fritzsche, H. (1999) High base pair opening rates in tracts of GC base pairs. J. Biol. Chem. 274, 6957-6962.
48. Futscher, B. W., Pieper, R. O., Dalton, W. S., and Erickson, L. C. (1992) Gene-specific DNA interstrand cross-links produced by nitrogen mustard in the human tumor cell line Colo320HSR. Cell Growth Differ. 3, 217-223.